| This week's sponsor is Patheon, part of Thermo Fisher Scientific. | | | Quickly proving efficacy in First-in-Human clinical trials is a make-or-break milestone for small biopharms whose hopes hinge upon one or two molecules. Read how CDMOs are helping these cash-strapped companies get to clinic faster. |
Today's Rundown Pfizer puts neuroscience at heart of new $600M VC fund Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs Axovant pivots with new gene therapy, Spark co-founder as CTO [Sponsored] It Might Be a Bumpy Ride: Why Life Sciences Companies Should Consider Embracing the New Wave of Change Secret Amazon research unit developing health tech with Fred Hutch: report Eisai and Biogen’s BACE drug lowers amyloid levels, but not Alzheimer’s symptoms Eisai, Purdue reveal eye-opening data for sleep drug lemborexant Gilead, Hookipa pen hepatitis B, HIV research collaboration Metacrine raises $65M to kick off NASH clinical testing Exact Sciences’ DNA blood test detects early-stage liver cancer with 93% sensitivity How different are I-O stars from Merck, Roche and Bristol-Myers? Depends who you ask Featured Story | | | Wednesday, June 6, 2018 Pfizer has committed $600 million to its VC fund. The Big Pharma is setting aside 25% of the money for investments in neuroscience startups, giving it a way to continue participating in the field despite its retreat from in-house R&D. |
|
|
| This week's sponsor is SNBL. | | | Does Your CNS Program Need a Boost? The Shortest Distance is a Straight Line. Nose-to-Brain
Brain delivery can be a hurdle for CNS drugs targeting unmet medical needs. Our technology can deliver your drug directly to the brain. Find out how! |
Top Stories Wednesday, June 6, 2018 Genentech has signed a multiyear contract to pan the diverse bacteria living in the digestive tract for biomarker signatures of drug response, new live bacterial therapeutics and novel targets for inflammatory bowel disease. Wednesday, June 6, 2018 After a disastrous year in which its Alzheimer’s attempts blew up and the once biotech star David Hung jumped ship, Axovant is continuing its change-up with a new focus and a new executive. Monday, June 4, 2018 Changes in technology and geopolitics, coupled with U.S. tax reform and new financial accounting standards, are creating disruption in accounting and financial reporting for life sciences companies. Tuesday, June 5, 2018 More details have become public regarding Amazon’s secret “skunk works” division, which is focused on innovative pursuits that could expand the company’s reach in healthcare technology, cancer research and medical records, according to reports from CNBC. Wednesday, June 6, 2018 While Eisai and Biogen’s oral BACE inhibitor elenbecestat was able to demonstrate a reduction in amyloid beta levels in 35 patients with Alzheimer’s disease, it failed to slow the decline of clinical symptoms more than placebo in exploratory endpoints. Wednesday, June 6, 2018 Eisai and Purdue Pharma have presented new clinical trial results of their dual orexin receptor antagonist lemborexant, which they think could become a new force in the sleep disorder market. Wednesday, June 6, 2018 Gilead has licensed immunization technologies from Hookipa Biotech for use against hepatitis B and HIV. The big biotech is paying $10 million (€8.5 million) upfront and committing to milestones that could exceed $400 million to snag exclusive rights to two technologies in the indications. Wednesday, June 6, 2018 Metacrine raised $65 million to launch phase 1 clinical development of its FXR agonist program in NASH and gastrointestinal diseases, set to start later this month. Tuesday, June 5, 2018 A DNA-based blood test developed by Exact Sciences and the Mayo Clinic accurately detected liver cancer across all stages of the disease and outperformed the most commonly used serum test in a phase 2 clinical validation study. Wednesday, June 6, 2018 It’s no secret that most ASCO watchers decided Merck's data on immuno-oncology star Keytruda would cement its position as king of the lung cancer market. Its rivals have a thing or two to say, though—chiefly, that differences between their drugs and Keytruda are small to nonexistent. Who's right? | This week's sponsor is LabConnect. | | | SciOps Provides Solutions for Lost Samples, Missed Timelines and Scientific Personnel Needs
Managing outsourced studies can be challenging. Read how our team’s functional and strategic resourcing services allow you to focus on other core competencies. |
Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Presented By: Covance A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today! Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Innovation, Collaboration and Entrepreneurship in Drug Discovery June 28, 2018 | Cambridge, UK CBI’s 14th Annual Medical Device Compliance Congress (MDCC) June 14-15, 2018 | Chicago, IL Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! |
